Fabian Müller

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Escherichia Coli

Optical Coherence Tomography

Top Venues

Clinical pharmacology and therapeutics

Molecular pharmaceutics

European journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Arne Gessner, Martin F Fromm, Pia Wenisch, Markus R Heinrich, Peter Stopfer, Martin F Fromm, Fabian Müller
New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans. Clinical pharmacology and therapeutics (2024)
Arne Gessner, Fabian Müller, Pia Wenisch, Markus R Heinrich, Jörg König, Peter Stopfer, Martin F Fromm
A metabolomic analysis of sensitivity and specificity of 23 previously proposed biomarkers for renal transporter-mediated drug-drug interactions. Clinical pharmacology and therapeutics (2023)
Fabian Müller, Kathrin Hohl, Sascha Keller, Sven Schmidt-Gerets, Birgit Deutsch, Annette Schuler-Metz, Martin F Fromm, Peter Stopfer, Arne Gessner
N 1 -Methylnicotinamide as Biomarker for MATE-Mediated Renal Drug-Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid. Clinical pharmacology and therapeutics (2023)
Fabian Müller, Kathrin Hohl, Sascha Keller, Sven Schmidt-Gerets, Birgit Deutsch, Annette Schuler-Metz, Martin F Fromm, Peter Stopfer, Arne Gessner
N 1 -methylnicotinamide as biomarker for MATE-mediated renal drug-drug interactions: impact of cimetidine, rifampin, verapamil, and probenecid. Clinical pharmacology and therapeutics (2023)
Fabian Müller, Michael Sand, Glen Wunderlich, Jasmin Link, Christian Schultheis, Chantaratsamon Dansirikul, Rucha Sane, Roman Laszlo, Jürgen M Steinacker
The effect of BI 409306 on heart rate in healthy volunteers: a randomised, double-blind, placebo-controlled, crossover study. European journal of clinical pharmacology 78 (5) (2022)
Fabian Müller, Dietmar Weitz, Katharina Mertsch, Jörg König, Martin F Fromm
Importance of OCT2 and MATE1 for the Cimetidine-Metformin Interaction: Insights from Investigations of Polarized Transport in Single- And Double-Transfected MDCK Cells with a Focus on Perpetrator Disposition. Molecular pharmaceutics 15 (8) (2018)
Fabian Müller, Dietmar Weitz, Volker Derdau, Martin Sandvoss, Katharina Mertsch, Jörg König, Martin F Fromm
Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine. Molecular pharmaceutics 14 (9) (2017)